Titre : Burkholderiaceae

Burkholderiaceae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Exercise Test
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Burkholderiaceae : Questions médicales les plus fréquentes", "headline": "Burkholderiaceae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Burkholderiaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-16", "dateModified": "2025-03-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Burkholderiaceae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Burkholderiales", "url": "https://questionsmedicales.fr/mesh/D000073556", "about": { "@type": "MedicalCondition", "name": "Burkholderiales", "code": { "@type": "MedicalCode", "code": "D000073556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia", "alternateName": "Burkholderia", "url": "https://questionsmedicales.fr/mesh/D019117", "about": { "@type": "MedicalCondition", "name": "Burkholderia", "code": { "@type": "MedicalCode", "code": "D019117", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia cepacia complex", "alternateName": "Burkholderia cepacia complex", "url": "https://questionsmedicales.fr/mesh/D042602", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia complex", "code": { "@type": "MedicalCode", "code": "D042602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia cenocepacia", "alternateName": "Burkholderia cenocepacia", "url": "https://questionsmedicales.fr/mesh/D057508", "about": { "@type": "MedicalCondition", "name": "Burkholderia cenocepacia", "code": { "@type": "MedicalCode", "code": "D057508", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.490" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia cepacia", "alternateName": "Burkholderia cepacia", "url": "https://questionsmedicales.fr/mesh/D016956", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia", "code": { "@type": "MedicalCode", "code": "D016956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Burkholderia cenocepacia", "alternateName": "Burkholderia cenocepacia", "url": "https://questionsmedicales.fr/mesh/D057508", "about": { "@type": "MedicalCondition", "name": "Burkholderia cenocepacia", "code": { "@type": "MedicalCode", "code": "D057508", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.490" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia cepacia", "alternateName": "Burkholderia cepacia", "url": "https://questionsmedicales.fr/mesh/D016956", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia", "code": { "@type": "MedicalCode", "code": "D016956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.500" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia gladioli", "alternateName": "Burkholderia gladioli", "url": "https://questionsmedicales.fr/mesh/D042725", "about": { "@type": "MedicalCondition", "name": "Burkholderia gladioli", "code": { "@type": "MedicalCode", "code": "D042725", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.355" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia mallei", "alternateName": "Burkholderia mallei", "url": "https://questionsmedicales.fr/mesh/D042726", "about": { "@type": "MedicalCondition", "name": "Burkholderia mallei", "code": { "@type": "MedicalCode", "code": "D042726", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.477" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia pseudomallei", "alternateName": "Burkholderia pseudomallei", "url": "https://questionsmedicales.fr/mesh/D016957", "about": { "@type": "MedicalCondition", "name": "Burkholderia pseudomallei", "code": { "@type": "MedicalCode", "code": "D016957", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.600" } } } ] }, { "@type": "MedicalWebPage", "name": "Cupriavidus", "alternateName": "Cupriavidus", "url": "https://questionsmedicales.fr/mesh/D049921", "about": { "@type": "MedicalCondition", "name": "Cupriavidus", "code": { "@type": "MedicalCode", "code": "D049921", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cupriavidus necator", "alternateName": "Cupriavidus necator", "url": "https://questionsmedicales.fr/mesh/D020118", "about": { "@type": "MedicalCondition", "name": "Cupriavidus necator", "code": { "@type": "MedicalCode", "code": "D020118", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.200.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Ralstonia", "alternateName": "Ralstonia", "url": "https://questionsmedicales.fr/mesh/D043367", "about": { "@type": "MedicalCondition", "name": "Ralstonia", "code": { "@type": "MedicalCode", "code": "D043367", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ralstonia pickettii", "alternateName": "Ralstonia pickettii", "url": "https://questionsmedicales.fr/mesh/D049920", "about": { "@type": "MedicalCondition", "name": "Ralstonia pickettii", "code": { "@type": "MedicalCode", "code": "D049920", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600.600" } } }, { "@type": "MedicalWebPage", "name": "Ralstonia solanacearum", "alternateName": "Ralstonia solanacearum", "url": "https://questionsmedicales.fr/mesh/D043368", "about": { "@type": "MedicalCondition", "name": "Ralstonia solanacearum", "code": { "@type": "MedicalCode", "code": "D043368", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Burkholderiaceae", "alternateName": "Burkholderiaceae", "code": { "@type": "MedicalCode", "code": "D042521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yusuke Takashima", "url": "https://questionsmedicales.fr/author/Yusuke%20Takashima", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Yousuke Degawa", "url": "https://questionsmedicales.fr/author/Yousuke%20Degawa", "affiliation": { "@type": "Organization", "name": "Sugadaira Research Station Mountain Science Center, University of Tsukuba." } }, { "@type": "Person", "name": "Tomoyasu Nishizawa", "url": "https://questionsmedicales.fr/author/Tomoyasu%20Nishizawa", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Hiroyuki Ohta", "url": "https://questionsmedicales.fr/author/Hiroyuki%20Ohta", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Kazuhiko Narisawa", "url": "https://questionsmedicales.fr/author/Kazuhiko%20Narisawa", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy and Safety of Exercise Testing and Rehabilitation for Aortic Dissection Patients: A SCOPING REVIEW.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36730592", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/HCR.0000000000000743" } }, { "@type": "ScholarlyArticle", "name": "The role of invasive cardiopulmonary exercise testing in patients with unexplained dyspnea: a systemic review.", "datePublished": "2022-11-08", "url": "https://questionsmedicales.fr/article/36345986", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/00015385.2022.2141434" } }, { "@type": "ScholarlyArticle", "name": "Coronary stenosis is a risk marker for impaired cardiac function on cardiopulmonary exercise test.", "datePublished": "2022-11-14", "url": "https://questionsmedicales.fr/article/36376809", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12872-022-02935-9" } }, { "@type": "ScholarlyArticle", "name": "Prognostic Value of Cardiopulmonary Exercise Test Parameters in Ventricular Assist Device Therapy.", "datePublished": "2022-09-07", "url": "https://questionsmedicales.fr/article/34494984", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MAT.0000000000001571" } }, { "@type": "ScholarlyArticle", "name": "Survey of exercise testing and training in cystic fibrosis clinics in the UK: a decade of progress.", "datePublished": "2023-04-28", "url": "https://questionsmedicales.fr/article/37116999", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-072461" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Proteobacteria", "item": "https://questionsmedicales.fr/mesh/D020560" }, { "@type": "ListItem", "position": 4, "name": "Betaproteobacteria", "item": "https://questionsmedicales.fr/mesh/D020562" }, { "@type": "ListItem", "position": 5, "name": "Burkholderiales", "item": "https://questionsmedicales.fr/mesh/D000073556" }, { "@type": "ListItem", "position": 6, "name": "Burkholderiaceae", "item": "https://questionsmedicales.fr/mesh/D042521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Burkholderiaceae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Burkholderiaceae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Burkholderiaceae", "description": "Comment diagnostiquer une infection par Burkholderiaceae ?\nQuels tests sont utilisés pour identifier Burkholderia ?\nLes symptômes aident-ils au diagnostic ?\nLes tests sérologiques sont-ils utiles ?\nQuelle est l'importance de l'antibiogramme ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Burkholderiaceae", "description": "Quels sont les symptômes d'une infection par Burkholderia ?\nLes infections pulmonaires sont-elles fréquentes ?\nBurkholderia peut-elle causer des infections cutanées ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de Burkholderia ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Burkholderiaceae", "description": "Comment prévenir les infections par Burkholderia ?\nLes vaccinations sont-elles efficaces ?\nLes personnes à risque doivent-elles être surveillées ?\nLes mesures d'hygiène hospitalière sont-elles importantes ?\nLes équipements de protection individuelle sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Burkholderiaceae", "description": "Quel est le traitement standard pour les infections par Burkholderia ?\nLes infections sont-elles résistantes aux antibiotiques ?\nDes traitements alternatifs existent-ils ?\nLe traitement préventif est-il possible ?\nQuelle est la durée du traitement antibiotique ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Burkholderiaceae", "description": "Quelles sont les complications possibles d'une infection par Burkholderia ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nLes infections peuvent-elles entraîner des hospitalisations prolongées ?\nQuelles sont les séquelles possibles après une infection ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Burkholderiaceae", "description": "Quels sont les principaux facteurs de risque d'infection ?\nLes patients atteints de cysticfibrose sont-ils à risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes travailleurs de la santé sont-ils exposés ?\nLes voyages dans certaines régions augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Burkholderiaceae ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité aux antibiotiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Burkholderia ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests PCR et des séquençages génétiques sont souvent utilisés pour l'identification." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques peuvent orienter vers une infection, mais ne suffisent pas." } }, { "@type": "Question", "name": "Les tests sérologiques sont-ils utiles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques peuvent aider, mais ne sont pas toujours fiables pour Burkholderia." } }, { "@type": "Question", "name": "Quelle est l'importance de l'antibiogramme ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'antibiogramme est crucial pour déterminer la sensibilité aux antibiotiques des souches isolées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection par Burkholderia ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et parfois des lésions cutanées." } }, { "@type": "Question", "name": "Les infections pulmonaires sont-elles fréquentes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections pulmonaires, notamment chez les patients immunodéprimés, sont courantes." } }, { "@type": "Question", "name": "Burkholderia peut-elle causer des infections cutanées ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections cutanées peuvent survenir, surtout après des blessures ou des brûlures." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes neurologiques peuvent apparaître, mais ils sont moins fréquents et souvent graves." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de Burkholderia ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon l'espèce de Burkholderia et l'état du patient." } }, { "@type": "Question", "name": "Comment prévenir les infections par Burkholderia ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une bonne hygiène, des soins appropriés des plaies et l'évitement des contacts à risque." } }, { "@type": "Question", "name": "Les vaccinations sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Burkholderia." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles être surveillées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées ou avec des maladies chroniques doivent être surveillées de près." } }, { "@type": "Question", "name": "Les mesures d'hygiène hospitalière sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mesures strictes d'hygiène hospitalière sont essentielles pour prévenir les infections nosocomiales." } }, { "@type": "Question", "name": "Les équipements de protection individuelle sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation d'équipements de protection individuelle est recommandée dans les milieux à risque." } }, { "@type": "Question", "name": "Quel est le traitement standard pour les infections par Burkholderia ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut des antibiotiques comme la céftazidime ou le meropenem." } }, { "@type": "Question", "name": "Les infections sont-elles résistantes aux antibiotiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches de Burkholderia montrent une résistance significative aux antibiotiques." } }, { "@type": "Question", "name": "Des traitements alternatifs existent-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs peuvent inclure des combinaisons d'antibiotiques ou des thérapies ciblées." } }, { "@type": "Question", "name": "Le traitement préventif est-il possible ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement préventif peut être envisagé pour les patients à risque élevé d'infection." } }, { "@type": "Question", "name": "Quelle est la durée du traitement antibiotique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie, mais elle est généralement de 2 à 4 semaines selon la gravité." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection par Burkholderia ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des septicémies, des infections pulmonaires graves et des abcès." } }, { "@type": "Question", "name": "Les infections peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections par Burkholderia peuvent être mortelles, surtout chez les patients à risque." } }, { "@type": "Question", "name": "Y a-t-il des complications neurologiques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, bien que rares, peuvent survenir, entraînant des séquelles." } }, { "@type": "Question", "name": "Les infections peuvent-elles entraîner des hospitalisations prolongées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections graves par Burkholderia peuvent nécessiter des hospitalisations prolongées." } }, { "@type": "Question", "name": "Quelles sont les séquelles possibles après une infection ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les séquelles peuvent inclure des problèmes respiratoires chroniques ou des troubles neurologiques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent l'immunodépression, les maladies chroniques et les traumatismes." } }, { "@type": "Question", "name": "Les patients atteints de cysticfibrose sont-ils à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients atteints de cysticfibrose sont particulièrement vulnérables aux infections par Burkholderia." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru d'infections en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les travailleurs de la santé sont-ils exposés ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs de la santé peuvent être exposés à des souches résistantes dans les hôpitaux." } }, { "@type": "Question", "name": "Les voyages dans certaines régions augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions où Burkholderia est endémique peut augmenter le risque d'infection." } } ] } ] }

Sources (10000 au total)

Efficacy and Safety of Exercise Testing and Rehabilitation for Aortic Dissection Patients: A SCOPING REVIEW.

Although physical exercise has established benefits for long-term cardiovascular health, concern regarding further aortic events has limited the evidence for exercise among aortic dissection (AD) pati... A scoping review of the literature search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). Eligibilit... Six observational studies were included with a total of 381 patients with AD, all of whom underwent surgical intervention. Study heterogeneity prevented data synthesis and a formal systematic review, ... Within the context of apparent benefits from cardiovascular testing and rehabilitation for patients with AD who have undergone intervention, this scoping review highlights the need for increased compa...

The role of invasive cardiopulmonary exercise testing in patients with unexplained dyspnea: a systemic review.

Dyspnoea is a common complaint that often remains unexplained with no diagnosis and poor management despite extensive, repetitive and costly testing. Invasive cardiopulmonary testing has been used in ... We performed a literature review in accordance with PRISMA, analysing articles published in peer-reviewed journals between January 1st 1985 and January 31st 2020, available in 3 databases. The aim was... Invasive cardiopulmonary exercise test is a useful tool for identifying the cause of unexplained dyspnoea. It can be helpful in early recognition and prognostication of patients with heart failure wit...

Coronary stenosis is a risk marker for impaired cardiac function on cardiopulmonary exercise test.

Cardiac function varies in different ways in ischemic heart disease (IHD). We aimed to evaluate the characteristics of cardiac function on cardiopulmonary exercise test (CPET) in IHD with different co... Totally 614 patients with IHD were divided into non-obstructive coronary artery disease (NOCAD) (stenosis < 50%), obstructive coronary artery disease (OCAD) (stenosis 50-90%) and severe OCAD ( stenosi... Generally, the values of VO... IHD with increasing atherosclerotic burdens were associated with impaired cardiac output and chronotropic response on CPET. NOCAD should be given more early prevention and rigorous follow-up....

Survey of exercise testing and training in cystic fibrosis clinics in the UK: a decade of progress.

Regular exercise testing is recommended for people with cystic fibrosis (pwCF), as is the provision and regular review of exercise training programmes. A previous survey on exercise testing and traini... Cross-sectional, online survey.... A survey was distributed electronically to UK CF clinics and completed by the individual primarily responsible for exercise services. Descriptive statistics and qualitative analyses were undertaken.... In total, 31 CF centres participated, representing ~50% of UK specialist clinics. Of these, 94% reported using exercise testing, 48% of which primarily use cardiopulmonary exercise testing. Exercise t... These data demonstrate that the majority of respondent centres in the UK now offer some exercise testing and training advice for pwCF, representing a marked improvement over the past decade. However, ...

Aerobic Exercise Prescription in Cardiac Rehabilitation Based on Heart Rate from Talk Test Stages and 6-Minute Walk Test.

Although the Talk Test (TT) is a reliable and low-cost test, its use for aerobic exercise prescription is still limited.... To analyze the heart rate (HR) in the stages of the TT and at the peak of the 6-minute walk test (6MWT) as a parameter to prescribe aerobic exercise compared with HR at the first and second ventilator... Individuals with cardiovascular disease attended three assessment days: 1) anamnesis and CPET; 2) 6MWT; and 3) TT. One-way repeated measures ANOVA or Friedman's test were used to compare HR at VT1 and... The study included 22 cardiac patients (13 men, 61 ± 8 years). HR at VT1 was similar to HR at TT+ (p = 0.987) and TT± (p = 0.154), and moderately correlated with TT+ (r = 0.479, p = 0.024). HR at VT2 ... HR at TT+ and TT- reflect HR at VT1 and VT2, respectively, differently from 6MWT, which was similar only to VT2. TT may be an objective test to assist aerobic exercise prescription in cardiac rehabili...